Van Cutsem E - Search Results

1

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.

Normanno N, Tejpar S, Morgillo F, De Luca A, Van Cutsem E, Ciardiello F. Normanno N, et al. Among authors: van cutsem e. Nat Rev Clin Oncol. 2009 Sep;6(9):519-27. doi: 10.1038/nrclinonc.2009.111. Epub 2009 Jul 28. Nat Rev Clin Oncol. 2009. PMID: 19636327 Review.

2

Screening for colorectal cancer.

Van Cutsem E, Tejpar S, Rutgeerts P, Janssens J. Van Cutsem E, et al. Acta Gastroenterol Belg. 1995 Sep-Dec;58(5-6):397-404. Acta Gastroenterol Belg. 1995. PMID: 8775996

3

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).

Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, Van Cutsem E, Bapat B, van Roy F, Cassiman JJ, Alman BA. Tejpar S, et al. Among authors: van cutsem e, van roy f. Oncogene. 1999 Nov 11;18(47):6615-20. doi: 10.1038/sj.onc.1203041. Oncogene. 1999. PMID: 10597266

4

Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).

Tejpar S, Li C, Yu C, Poon R, Denys H, Sciot R, Van Cutsem E, Cassiman JJ, Alman BA. Tejpar S, et al. Among authors: van cutsem e. Br J Cancer. 2001 Jul 6;85(1):98-101. doi: 10.1054/bjoc.2001.1857. Br J Cancer. 2001. PMID: 11437409 Free PMC article.

5

The molecular basis of colorectal cancer.

Tejpar S, Cassiman JJ, Van Cutsem E. Tejpar S, et al. Among authors: van cutsem e. Acta Gastroenterol Belg. 2001 Jul-Sep;64(3):249-54. Acta Gastroenterol Belg. 2001. PMID: 11680042 Review.

6

Molecular and genetic defects in colorectal tumorigenesis.

Tejpar S, Van Cutsem E. Tejpar S, et al. Among authors: van cutsem e. Best Pract Res Clin Gastroenterol. 2002 Apr;16(2):171-85. doi: 10.1053/bega.2001.0279. Best Pract Res Clin Gastroenterol. 2002. PMID: 11969232 Review.

7

Pathogenic mutations and rare variants of the APC gene identified in 75 Belgian patients with familial adenomatous polyposis by fluorescent enzymatic mutation detection (EMD).

Michils G, Tejpar S, Fryns JP, Legius E, Van Cutsem E, Cassiman JJ, Matthijs G. Michils G, et al. Among authors: van cutsem e. Eur J Hum Genet. 2002 Sep;10(9):505-10. doi: 10.1038/sj.ejhg.5200825. Eur J Hum Genet. 2002. PMID: 12173026

8

Molecular defects in colorectal tumorigenesis.

Tejpar S, van Cutsem E. Tejpar S, et al. Among authors: van cutsem e. Drugs Today (Barc). 2003;39 Suppl C:111-8. Drugs Today (Barc). 2003. PMID: 14988749 Review.

9

Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.

Van Cutsem E, Verslype C, Tejpar S. Van Cutsem E, et al. Semin Oncol. 2005 Feb;32(1):43-51. doi: 10.1053/j.seminoncol.2004.09.028. Semin Oncol. 2005. PMID: 15726505 Review.

10

Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study.

Tejpar S, Piessevaux H, Claes K, Piront P, Hoenderop JG, Verslype C, Van Cutsem E. Tejpar S, et al. Among authors: van cutsem e. Lancet Oncol. 2007 May;8(5):387-94. doi: 10.1016/S1470-2045(07)70108-0. Lancet Oncol. 2007. PMID: 17466895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

741 results

Search Page

Filters